Crizotinib
Crizotinib is an ATP-competitive small-molecule tyrosine kinases inhibitor of c-MET (IC50: 8 nM) and ALK (IC50: 20 nM) receptor.
| Catalog Number | T1661 |
| Alternative Name(s) | PF-02341066 |
| Research Area | Autophagy|||Tyrosine Kinase/Adaptors|||Angiogenesis|||Immunology/Inflammation |
| Molecular Formula | C21H22Cl2FN5O |
| CAS# | 877399-52-5 |
| Purity | 99.35% |
| SMILES | C[C@@H](Oc1cc(cnc1N)-c1cnn(c1)C1CCNCC1)c1c(Cl)ccc(F)c1Cl |
| Size | 200 mg |
| Supplier Page | https://www.targetmol.com/compound/Crizotinib |
| Additional Information | https://www.targetmol.com/datasheet/T1661 |